Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

driveR: A Novel Method for Prioritizing Cancer Driver Genes Using Somatic Genomics Data

View through CrossRef
Abstract Cancer develops due to “driver” alterations. Numerous approaches exist for predicting cancer drivers from cohort-scale genomic data. However, methods for personalized analysis of driver genes are underdeveloped. In this study, we developed a novel personalized/batch analysis approach for driver gene prioritization utilizing somatic genomic data, called driveR. Combining genomic information and prior biological knowledge, driveR accurately prioritizes cancer driver genes via a multi-task learning model. Testing on 28 different datasets, this study demonstrates that driveR performs adequately, outperforms existing approaches, and is an accurate and easy-to-utilize approach for prioritizing driver genes in cancer genomes. driveR is available on CRAN: https://cran.r-project.org/package=driveR .
Title: driveR: A Novel Method for Prioritizing Cancer Driver Genes Using Somatic Genomics Data
Description:
Abstract Cancer develops due to “driver” alterations.
Numerous approaches exist for predicting cancer drivers from cohort-scale genomic data.
However, methods for personalized analysis of driver genes are underdeveloped.
In this study, we developed a novel personalized/batch analysis approach for driver gene prioritization utilizing somatic genomic data, called driveR.
Combining genomic information and prior biological knowledge, driveR accurately prioritizes cancer driver genes via a multi-task learning model.
Testing on 28 different datasets, this study demonstrates that driveR performs adequately, outperforms existing approaches, and is an accurate and easy-to-utilize approach for prioritizing driver genes in cancer genomes.
driveR is available on CRAN: https://cran.
r-project.
org/package=driveR .

Related Results

BRDriver: Breast Cancer Driver Gene Predictor
BRDriver: Breast Cancer Driver Gene Predictor
Abstract The breast cancer mortality rate is high in developing countries as the early detection of cancer is deficient in patients. The identifi...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Multi-omic data helps improve prediction of personalised tumor suppressors and oncogenes
Multi-omic data helps improve prediction of personalised tumor suppressors and oncogenes
ABSTRACT The progression of tumorigenesis starts with a few mutational and structural driver events in the cell. Various cohort-based computational tools exist to i...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Abstract LB-401: Functional impact bias reveals cancer drivers
Abstract LB-401: Functional impact bias reveals cancer drivers
Abstract Currently, one of the main challenges in cancer genomics is the identification of driver genes and pathways among all the altered genes in a cohort of tumor...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose: To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...

Back to Top